Adverum Biotechnologies Inc (ADVM)
2.60 x 1 2.99 x 3
Post-market by (Cboe BZX)
2.88 -0.03 (-1.03%) 04/28/25 [NASDAQ]
2.60 x 1 2.99 x 3
Post-market 2.94 +0.06 (+2.08%) 16:50 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select FieldsSymbol | ADVM | IKNA | ARTV | ||
Company | Adverum Biotechnologies Inc | Ikena Oncology Inc | Artiva Biotherapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 2.94 | 1.2300 | 2.47 | ||
High | 2.97 | 1.3600 | 2.47 | ||
Low | 2.64 | 1.2300 | 2.27 | ||
Last | 2.88 | 1.2700 | 2.45 | ||
Change | -0.03 | +0.0800 | -0.02 | ||
% Change | -1.03% | +6.72% | -0.81% | ||
Volume | 779,900 | 150,300 | 187,000 | ||
20-Day Average Volume | 321,160 | 96,620 | 699,365 | ||
Previous Close | 2.91 | 1.1900 | 2.47 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | No | No | ||
Technicals | |||||
20-Day Moving Average | 3.38 | 1.1610 | 2.42 | ||
20-Day Raw Stochastic | 11.35% | 76.88% | 21.14% | ||
20-Day Relative Strength | 37.40% | 51.86% | 40.39% | ||
Weighted Alpha | -74.73 | -21.04 | -81.97 | ||
Today's Opinion | 100% Sell | 88% Sell | N/A | ||
Previous Opinion | 100% Sell | 88% Sell | N/A | ||
Last Month's Opinion | 40% Sell | 100% Sell | N/A | ||
Performance | |||||
5-Days | |||||
%Chg | +5.49% since 04/21/25 | +11.40% since 04/21/25 | +2.08% since 04/21/25 | ||
Low | 2.64 on 04/28/25 | 1.0988 on 04/22/25 | 2.27 on 04/28/25 | ||
High | 3.11 on 04/24/25 | 1.3600 on 04/28/25 | 2.55 on 04/23/25 | ||
1-Month | |||||
%Chg | -37.53% since 03/28/25 | -3.79% since 03/28/25 | -22.47% since 03/28/25 | ||
Low | 2.64 on 04/28/25 | 0.9707 on 04/09/25 | 1.78 on 04/09/25 | ||
High | 4.76 on 03/31/25 | 1.3600 on 04/28/25 | 4.95 on 04/07/25 | ||
3-Month | |||||
%Chg | -34.99% since 01/28/25 | -14.19% since 01/28/25 | -55.94% since 01/28/25 | ||
Low | 2.64 on 04/28/25 | 0.9707 on 04/09/25 | 1.78 on 04/09/25 | ||
High | 5.72 on 03/21/25 | 1.6000 on 02/13/25 | 6.54 on 03/12/25 | ||
6-Month | |||||
%Chg | -63.64% since 10/28/24 | -26.16% since 10/28/24 | -76.89% since 10/28/24 | ||
Low | 2.64 on 04/28/25 | 0.9707 on 04/09/25 | 1.78 on 04/09/25 | ||
High | 8.18 on 11/11/24 | 1.9400 on 12/23/24 | 15.49 on 11/07/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 60,166 | 61,288 | 59,689 | ||
Shares Outstanding, K | 20,891 | 48,258 | 24,363 | ||
Annual Sales | 1,000,000 | 0 | 250,000 | ||
Annual Net Income | -130,930,000 | -49,230,000 | -65,370,000 | ||
Last Quarter Sales | 1,000,000 | 0 | 0 | ||
Last Quarter Net Income | -27,130,000 | -9,120,000 | -17,840,000 | ||
60-Month Beta | 1.10 | 0.48 | N/A | ||
Per-Share Information | |||||
Most Recent Earnings | -1.96 on 04/15/25 | -0.18 on 03/06/25 | -0.92 on 11/12/24 | ||
Latest Earnings Date | 05/08/25 | 05/12/25 | 06/23/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |